McKesson Corp., based in Irving, Texas, has agreed to acquire a controlling 70% stake in Community Oncology Revitalization Enterprise Ventures LLC for $2.49 billion. This entity, also known as Core Ventures, is a business and administrative services organization established by Florida Cancer Specialists & Research Institute, whose physicians will retain a minority interest. This acquisition supports McKesson’s strategy to advance community-based oncology care by integrating Core Ventures and Florida Cancer Specialists into its US Oncology Network. The move is expected to enhance patient outcomes, reduce care costs, and expand access to quality cancer care. McKesson's competitors, including Cencora Inc. and Cardinal Health Inc., were also interested in acquiring Florida Cancer Specialists. McKesson's shares have risen 19% this year, reflecting strong market confidence in its growth strategy.